Saved source record
[Focus on tirzepatide, a dual unimolecular GIP-GLP-1 receptor agonist in type 2 diabetes].
This is a source-metadata record last found in a complete check on Sep 28, 2026. It is not a Pependium assessment of safety or effectiveness. Check the original sources for current details, corrections and full methods.
Source status: This saved record has not yet had a scheduled exact-ID status check. Check its original source links.
Study metadata
- Study type
- Original study
- Study category (metadata hint)
- Human
- Source date
- Published: 2022 Aug 24
- Authors
- Scheen AJ, Radermecker RP, Paquot N
- Journal or registry
- Revue medicale suisse
- Registry study design
- Not reported
- Registry enrollment
- Not reported
- Funding agencies
- Not reported in source metadata
- Identifiers
- DOI: 10.53738/REVMED.2022.18.792.1539 · PMID: 36004653
- First found
- Sep 28, 2026
- Last found
- Sep 28, 2026
Original sources
Browse saved studies · Search live sources